Sellas Life Sciences Gets Favorable Meeting Feedback From FDA
By Chris Wack
Sellas Life Sciences Group has received favorable Type C meeting feedback from the Food and Drug Administration for its lead product, galinpepimut-S.
The recently concluded Type C meeting with the FDA covered the biopharmaceutical company's Chemistry, Manufacturing, and Controls sections in a potential biologics license application for galinpepimut-S.
Sellas submitted a CMC Briefing Package to the FDA, which provided an up-to-date overview of the extensive work completed for the galinpepimut-S CMC program and commercial manufacturing and regulatory plans. The FDA reviewed the package of data and accompanying questions to the agency and responded with favorable guidance.
The FDA also agreed on the company's proposed stability data generation plan for the commercial presentation of galinpepimut-S. Galinpepimut-S is expected to be stored at 2 degrees Celsius to 8 degrees.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
November 13, 2023 09:22 ET (14:22 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom